The Centers for Disease Control and Prevention says that the Federal Drug Administration has ended a program that provided ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Key Takeaways Moderna shares surged Tuesday after Canadian regulators approved the biotech firm’s updated COVID-19 ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Moderna (NYSE: MRNA) stock plunged Thursday on news it will be slashing its research and development budget by about 20% over ...

Shares of Moderna tumbled early Thursday after the vaccine developer said it was cutting research and development spending ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

For the first time in the U.K., the updated vaccine, Spikevax JN.1, will also be available to purchase privately for those ...

The GIANT Company announced today that updated 2024-2025 COVID-19 vaccines are now available in all GIANT and MARTIN’S ...